CollPlant Biotechnologies Current Assets

CollPlant Biotechnologies (CLGN) currently reports a current assets of $5.5M as of March 2026. That compares with $12M in the prior-year period — down 54.2% year over year. Use the charts on this page to explore CollPlant Biotechnologies's current assets history and peer comparisons.

CollPlant Biotechnologies's current assets decreased from $12M to $5.5M — a 54.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CollPlant Biotechnologies reported $5.5M in current assets as of March 2026. That compares with $12M in the prior-year period — down 54.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $5.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CollPlant Biotechnologies, and consider following CLGN for alerts when major investors trade the stock.

CollPlant Biotechnologies is classified in the Healthcare sector. On current assets, it currently shows $5.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLGN with unrelated industries.